Skip to main content

$0.056 -0.002 (-3.45%)

High

$0.06

Low

$0.06

Trades

69

Turnover

$115,211

Volume

1,984,515
30 June 2023 at 3:59pm
Register to track PYC and receive email alerts.

FIRST PATIENT DOSED IN EYE DISEASE CLINICAL TRIAL

StockBot

416,823 posts

PYC released this announcement to the ASX on 30 June 2023, 8:17. The announcement is marked as price sensitive, and is 3 page(s) in length and 252.93kb in size.

This is the most recent announcement released by PYC to the ASX. You can view all announcements from PYC and see how they appear on a price chart on the announcements page.

At the date of this announcement, PYC was 0.000% short sold according to ASIC data. It was ranked the 645th most shorted stock on the ASX. It is now ranked as the 409th most shorted stock on the ASX with 0.132% of total shares short sold as of the latest reported data (05 May 2025).

Other Recent Announcements from PYC
FIRST PATIENT DOSED IN EYE DISEASE CLINICAL TRIAL 30 June 2023, 8:17
Change of Director's Interest Notice 28 June 2023, 16:46
PYC Investor Update Presentation 16 June 2023, 8:32
Q2 Investor Call 16 June 2023 8 June 2023, 8:21
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track PYC and receive email alerts.